Life-course immunization: Benchmarking main markets and model countries

A new benchmark report on life-course immunization highlights the urgent need for changes in global, regional and national immunization policies and plans to reach WHO’s 2030 Immunization Agenda (IA2030) and the United Nations Decade of Healthy Ageing objectives. The need to extend the benefits of vaccination from early life to include the whole lifecycle – and adults in particular – is imperative.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)’s new publication, “Life-course immunization: Benchmarking main markets & model countries” provides a deep dive into the facts and figures and case studies from each world region, including suggestions on how we can better to adapt national immunization plans to ensure protection at all stages of life. Paula Barbosa, Associate Director, Vaccines Policy, has penned a blog on this latest report as well. 

You can find it here: Vaccines are crucial to lifelong health and future global health security  




Post author: Morgane De Pol (IFPMA)

Image credits: IFPMA